InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
T+90 hit rate
50%
T+90 mean return
+175.9%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Allen Robert D. III, Chief Scientific Officer. Officer active across 1 company, notably Invivyd, Inc.. Aggregated, 6 filings have been recorded. Split: 0 buy · 2 sells. Total volume traded: €24k. History available since 19 August 2025. The latest transaction was filed on 18 August 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations6 total
99,000 sharesCommon StockSEC:0001193125-26-057828:0
99,000 sharesCommon StockSEC:0001193125-26-057828
99,000 sharesCommon StockSEC:0000950170-25-110339
99,000 sharesCommon StockSEC:0000950170-25-110339:0
18,512 shares@ US$0.650243.6% of flowCommon StockSEC:0000950170-25-110339:1
27,420 shares@ US$0.566656.4% of flowCommon StockSEC:0000950170-25-110339:2
6 of 6 declarations
About Allen Robert D. III
Robert D. Allen III is the Chief Scientific Officer at Invivyd, Inc. He is responsible for leading the company's research and development initiatives, ensuring innovation and scientific advancement. With a strong background in science, he plays a crucial role in product strategy and the development of new technologies. His expertise contributes to the company's mission of improving health and well-being.
